Rosenstock stated in the Regeneron press release: These complete 26-week COURAGE results demonstrate a meaningful opportunity to preserve muscle mass while enhancing fat loss. Also noted: Numerical improvements in metabolic and lipid parameters, secondary and exploratory endpoints, were seen across all treatment groups, including improvements in waist circumference, blood pressure, cholesterol, triglycerides and A1C. Read the full press release:
Peppermint tea is another option
The goal in this phase is tolerance and consistency, not maximum fat loss
Eli Lilly has not submitted a New Drug Application
When treatment stops, many people notice their appetite and hunger returning to pre-medication levels over the first week or so
DISCUSSION Around 10 million people die from cancer each year worldwide, and this number is projected to double by 2050